UChicago Cancer

In a recent editorial, Alon Lazarovich, MD, MBA, and Scott Eggener, MD, highlighted how population growth, aging, lifestyle risk factors, ineffective preventive measures, and disparities could increase prostate cancer mortality rates by 2050.
https://ow.ly/NPpN50YniRr

Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer | NEJM Patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy proceed directly to radical cystectomy with pelvic lymph-node dissection. Perioperative therapy may ...

Congratulations to Dr. O'Donnell who is a co-author in a new @nejm.org article about practice-changing findings that resulted in a new FDA approval for bladder cancer! Read it at www.nejm.org/doi/full/10....

#AtTheForefront #CancerCare #CancerResearch #OncSky

Dr Rojek on Improving CAR T-Cell Therapies in Lymphoma | OncLive Alexandra Rojek, MD, discusses efforts to improve the safety and efficacy of CAR T-cell therapies in lymphoma through ongoing research.

Watch: Alexandra Rojek, MD, of @uchicagocancer.bsky.social discusses efforts to improve the safety and efficacy of CAR T-cell therapies in lymphoma through ongoing research.
Watch the full video here: www.onclive.com/view/dr-roje...
#oncology #hematology #CART #lymphoma

The @NCCN published new Clinical Practice Guidelines for #PediatricSoftTissueSarcomas, with a particular focus on rhabdomyosarcoma. The new guidelines provide evidence based, expert consensus driven recommendations for diagnosing and treating pediatric patients. https://ow.ly/IlmF50Yipwi

At the Equitable Cancer Care Summit, we will discuss how supportive oncology and survivorship care are strengthened when we partner with communities, integrate psychosocial care, and elevate the impact of community health workers.
wellnesshouse.org/equitable-ca...

ASH 2026 Guidelines for Frontline Management of Acute Lymphoblastic Leukemia in Adolescents and Young Adults Background: Adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) represent a unique population. Treatment regimens can vary signific

@ash.hematology.org's new guidelines for the management of ALL in AYA populations is out: doi.org/10.1182/bloo...

Several of our experts had a leading role in this publication, including Drs. Stock and Duval (@ayaoncologist.bsky.social). This incredible work is key in a rapidly advancing field!

Funding for #ClinicalTrials avail: our 2026 LMIC & Chicago-based RFPs are open. Read more and meet our Feb Researcher Spotlight: Dr. Austin Wesevich of @uchicagomedicine.bsky.social in our Feb newsletter: bit.ly/4cw4uu3 #Repurposing #ImpactPhilanthropy

In a recent study, Caner Saygin, MD and team examined a large group of adults with a rare, aggressive form of leukemia called TP53-mutant ALL and found key genetic changes that guide doctors to predict which pts may face more serious outcomes. @uchicagomedicine.bsky.social
https://ow.ly/cFsz50YgL2s

Olopade: “The genetic basis of every cancer, or everything we do, starts in Africa.” For Black History Month, Olopade reflects on mentorship, community, and her career in cancer genetics - The Cancer Letter When Olufunmilayo I. “Funmi” Olopade was born, the most common Nigerian career aspirations were pastor or teacher. Olopade’s father, a pastor, thought differently. He wanted his children to be scientists, economists, and doctors.  As the fifth of six children, Olopade was her parents’ “one last chance to find a doctor in the family,” she said. […]

Dr. @fOlopade was featured in @TheCancerLetter to tell her story of how she came to study genetics and why genetics are important for understanding why young women of African descent are at higher risk for aggressive breast cancers. cancerletter.com/black-histor...

Novel Solutions to Address the Rising Cost of Oncology Drugs program:
👂Hear from voices across policy, payers, clinicians, & patients
📅 March 4–5, 2026
📍 Georgetown Law, DC & Co-directed by our own Dr. Ratain.
👉 Free to join!
cpt.uchicago.edu/program/

A newly developed polygenic risk score model by Dezheng Huo, PhD and colleagues accurately predicts breast cancer risk in women of African ancestry. The scores from this new model are really helpful in detecting cancers early, particularly in women at high risk.
https://ow.ly/25Um50YeroR

Haven't registered yet for our 3rd Annual Multidisciplinary Breast Cancer Symposium on March 6? There's still time! Led by experts, Drs. @ritanandamd.bsky.social and Chen, it promises to be a great learning opportunity!

Visit cme.uchicago.edu/MBCS2026 to learn more

New study by Dezheng Huo, PhD, and team shows that the new polygenic risk models predict breast cancer risk accurately in women of African ancestry, helping early detection of cancers, particularly in high-risk women.
https://ow.ly/5lVV50Y7JKy

Our fantastic AYA APN, Theresa DiJosepsh, is a co-author on a recent piece in the Clinical Journal of Oncology Nursing about the value and role of APPs in AYA oncology! Read the piece at www.ons.org/publications...

#AYAOncology #APPs #CancerCare

Don't miss our Organ Preservation & Survival in Head & Neck Cancer Conference, coming up March 6th! Led by several @uchicagomedicine.bsky.social experts! Learn more/register at cme.uchicago.edu/OPSHNC26

We join our colleagues across the globe recognizing today as #WorldCancerDay. Every experience with cancer is unique and it will take all of us, united, to create a world where we look beyond the disease and see the person before the patient.

Dr. Funmi Olopade shares good news about the The Wisdom Study, which is making breast cancer screening and risk assessment more personalized.

🔥Hot off the press: UChicago Cancer researchers have developed new polygenic models to accurately predict breast cancer risk in women of African Ancestry. These models could support earlier screening, particularly for high-risk women. @uchicagoobgyn.bsky.social
https://ow.ly/5lVV50Y7JKy

Thank you to Stacy Tessler Lindau, MD, MA, of @uchicagocancer.bsky.social for stopping by for an excellent interview detailing the ongoing bionic breast project! Check out onclive.com for clips from the interview. #oncology #bcsm

Thank you to Alexandra Rojek, MD, of @uchicagocancer.bsky.social for participating in an interview which covered the evolving roles of CAR T-cell therapy and bispecifics in lymphoma! Check out our short on the topic which is live on onclive.com #oncology #hematology #CART #bispecifics

January is #CervicalCancerAwarenessMonth. Learn from Dr. Han Cun why screening for this cancer is so important.

Dr. Smith has a new article on @usatoday.com about the importance of survivorship care for those who have had cancer, especially as research and care innovations have improved survival rates and longevity! Read her insights: www.usatoday.com/story/opinio...

#AtTheForefront #CancerCare

Post ASH Annual Meeting - Hematology University of Chicago Post ASH Annual Meeting - American Society of Hematology

TOMORROW!! If you haven't registered yet, there's still time to join our team for Post ASH!

More at www.chicagopostash.com

#AtTheForefront #PostASH #Hematology

A huge thank you to Sonali Smith, MD, of @uchicagocancer.bsky.social for stopping by for an interview covering advances in CAR T-cell therapy and the role of clinical trials in cancer care. Check out onclive.com for clips from the interview and an upcoming podcast episode! #oncology #hematology

Thank you to Alex Pearson, MD, of @uchicagocancer.bsky.social for an excellent conversation on the evolving role of AI in oncology! Be sure to watch onclive.com for the highlights of the discussion. #oncology #medtwitter #AI

Alexandra Rojek, MD, of @uchicagocancer.bsky.social stopped by for an interview to discuss the exciting future of CAR T-cell therapy and bispecifics in lymphoma care. Check out www.onclive.com for highlights of the conversation. #oncology #hematology #CART #lymphoma

We are excited to be on-site today at @uchicagocancer.bsky.social with some exciting interviews lined up with experts spanning topics including clinical trials, advances in CAR T-cell therapy, AI in oncology, and more! Stay tuned to onclive.com for our coverage. #oncology #AI #CART #hematology

Clinicians from UChicago Medicine Crown Point were proud to attend and support the American Cancer Society’s Diamonds and Ice Gala. We are grateful for our team and their commitment to the fight against cancer.

The new UChicago Medicine Ralph Lauren Center, funded by the Ralph Lauren Corporate Foundation, will offer access to cancer prevention, treatment, and support services, helping to close longstanding gaps in cancer care across the Chicagoland area.
https://ow.ly/kuCX50Y1jYL